Literature DB >> 24559780

Nursing research in the Gynecologic Oncology Group.

Heidi S Donovan, Susan Nolte, Robert P Edwards, Lari Wenzel.   

Abstract

OBJECTIVES: To review nursing science history within the Gynecology Oncology Group (GOG); to discuss challenges of nursing science in the cooperative group (CG) using a current nurse-led protocol (GOG-0259) as an exemplar; and to propose recommendations to advance nursing science in the CG setting. DATA SOURCES: Indexed citations and personal experience.
CONCLUSION: Benefits of CG research include opportunities for inter-disciplinary collaboration and ability to rapidly accrue large national samples. Challenges include limited resources to support non-treatment trials, a burdensome protocol approval process, and lack of experience with nursing/quality-of-life intervention studies. Formal GOG structures need to evolve to encourage nurse scientists to become active members; promote collaboration between experienced GOG advanced practice nurses and nurse scientists to identify nursing research priorities; and consider new funding sources to support pilot intervention studies. IMPLICATIONS FOR NURSING PRACTICE: Understanding the CG research process is critical for nurse scientists. A multi-disciplinary team of CG leaders can help investigators navigate a complex research environment and increase awareness of the value of nursing research.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cooperative group; Gynecological Oncology Group; clinical trial; nursing science

Mesh:

Year:  2013        PMID: 24559780      PMCID: PMC4006357          DOI: 10.1016/j.soncn.2013.12.008

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  31 in total

1.  Positioning nursing research to contribute to the scientific mission of the Pediatric Oncology Cooperative Group.

Authors:  P S Hinds; J DeSwarte-Wallace
Journal:  Semin Oncol Nurs       Date:  2000-11       Impact factor: 2.315

2.  A phase I trial of prolonged oral etoposide and liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study.

Authors:  Peter G Rose; Michael Rodriguez; Joan Walker; Benjamin Greer; Nancy Fusco; William McGuire
Journal:  Gynecol Oncol       Date:  2002-04       Impact factor: 5.482

3.  A representational approach to patient education.

Authors:  H S Donovan; S Ward
Journal:  J Nurs Scholarsh       Date:  2001       Impact factor: 3.176

4.  Paclitaxel, carboplatin and pegylated liposomal doxorubicin in ovarian and peritoneal carcinoma: a phase I study of the Gynecologic Oncology Group.

Authors:  Peter G Rose; Benjamin E Greer; Ira R Horowitz; Maurie Markman; Nancy Fusco
Journal:  Gynecol Oncol       Date:  2006-09-07       Impact factor: 5.482

5.  Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group study.

Authors:  S O'Reilly; G F Fleming; S D Barker; J R Walczak; M A Bookman; W P McGuire; R J Schilder; R D Alvarez; D K Armstrong; I R Horowitz; R F Ozols; E K Rowinsky
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

6.  Quality of life after among ovarian germ cell cancer survivors: a narrative analysis.

Authors:  Melinda M Swenson; Jessica S MacLeod; Stephen D Williams; Anna M Miller; Victoria L Champion
Journal:  Oncol Nurs Forum       Date:  2003 May-Jun       Impact factor: 2.172

7.  Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study.

Authors:  M Markman; E Rowinsky; T Hakes; B Reichman; W Jones; J L Lewis; S Rubin; J Curtin; R Barakat; M Phillips
Journal:  J Clin Oncol       Date:  1992-09       Impact factor: 44.544

8.  Psychometric evaluation of two scales assessing functional status and peripheral neuropathy associated with chemotherapy for ovarian cancer: a gynecologic oncology group study.

Authors:  Lois Almadrones; Debroah B McGuire; Janet Ruth Walczak; Colleen M Florio; Chunqiao Tian
Journal:  Oncol Nurs Forum       Date:  2004-05       Impact factor: 2.172

9.  Online exclusive: functional integration of nursing research into a pediatric oncology cooperative group: finding common ground.

Authors:  Pamela S Hinds; Christina Baggott; Joetta DeSwarte-Wallace; Marilyn Dodd; Joan Haase; Marilyn Hockenberry; Casey Hooke; Patsy McGuire Cullen; Ida Moore; Lona Roll; Kathy Ruccione
Journal:  Oncol Nurs Forum       Date:  2003 Nov-Dec       Impact factor: 2.172

10.  Limited access trial using amifostine for protection against cisplatin- and three-hour paclitaxel-induced neurotoxicity: a phase II study of the Gynecologic Oncology Group.

Authors:  David H Moore; James Donnelly; William P McGuire; Lois Almadrones; David F Cella; Thomas J Herzog; Steven E Waggoner
Journal:  J Clin Oncol       Date:  2003-11-15       Impact factor: 44.544

View more
  2 in total

1.  Lessons Learned From a Practice-Based, Multisite Intervention Study With Nurse Participants.

Authors:  Christopher R Friese; Kari Mendelsohn-Victor; Pamela Ginex; Carol M McMahon; Alex J Fauer; Marjorie C McCullagh
Journal:  J Nurs Scholarsh       Date:  2017-01-18       Impact factor: 3.176

2.  All Hands on Deck: Nurses and Cancer Care Delivery in Women's Health.

Authors:  Jeanne Murphy; Michelle Mollica
Journal:  Front Oncol       Date:  2016-07-22       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.